MEGAN NIXON: Open Payments
NPI 1326502758 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 48 payments from 12 companies in 2025. Trend: 2023 $1,063 · 2024 $1,000 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $465 |
| Regeneron Healthcare Solutions, Inc. | 5 | $181 |
| GENZYME CORPORATION | 5 | $180 |
| PFIZER INC. | 6 | $113 |
| Amgen Inc. | 4 | $101 |
| Galderma Laboratories, L.P. | 2 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Kerecis Limited | 3 | $68 |
| ConvaTec Inc. | 2 | $46 |
| Organon LLC | 2 | $36 |
Products named: Bimzelx, DUPIXENT, LIBTAYO, CIBINQO, OTEZLA, NEMLUVIO, COSENTYX, Kerecis SurgiClose.
Industry payments across TX — which companies pay providers there.
